Abstract
Synthesis and characterization of some novel phosphonate derivatives as uPA inhibitors have been conducted. HOMO and LUMO energies, NPA charges, electrophilicity index and vibrational frequencies were calculated for the current and previously reported phosphonates. Based on the calculated properties, the results obtained indicate that the novel compounds are expected to be more potent than other phosphonates.
Keywords: DFT, electrophilicity, phosphonates synthesis, uPA inhibitors, SAR.
Current Organic Chemistry
Title:Synthesis, Characterization and Theoretical Studies of Novel Phosphonates as uPA Inhibitors
Volume: 18 Issue: 5
Author(s): Ahmed M. El-Nahas, Omar M. Ali, Nagy M. Khalifa and Basma S. Ghazal
Affiliation:
Keywords: DFT, electrophilicity, phosphonates synthesis, uPA inhibitors, SAR.
Abstract: Synthesis and characterization of some novel phosphonate derivatives as uPA inhibitors have been conducted. HOMO and LUMO energies, NPA charges, electrophilicity index and vibrational frequencies were calculated for the current and previously reported phosphonates. Based on the calculated properties, the results obtained indicate that the novel compounds are expected to be more potent than other phosphonates.
Export Options
About this article
Cite this article as:
M. El-Nahas Ahmed, M. Ali Omar, M. Khalifa Nagy and S. Ghazal Basma, Synthesis, Characterization and Theoretical Studies of Novel Phosphonates as uPA Inhibitors, Current Organic Chemistry 2014; 18 (5) . https://dx.doi.org/10.2174/13852728113176660134
DOI https://dx.doi.org/10.2174/13852728113176660134 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metalloprotein Inhibitors for the Treatment of Human Diseases
Current Topics in Medicinal Chemistry Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety
Current Medicinal Chemistry Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Bacterial Contamination of Platelets and Septic Transfusions: Review of the Literature and Discussion on Recent Patents About Biofilm Treatment
Recent Patents on Anti-Infective Drug Discovery Antiangiogenic Therapy
Current Pharmaceutical Design LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry Microtubule-targeting Anticancer Agents from Marine Natural Substance
Anti-Cancer Agents in Medicinal Chemistry Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science TEM8 Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases
Current Signal Transduction Therapy Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Current Gene Therapy Advances in the Management of Malignant Hemopathies: The Role of Statins
Recent Patents on DNA & Gene Sequences Immune Responses to Gene-Modified T Cells
Current Gene Therapy VEGF Signal System: The Application of Antiangiogenesis
Current Medicinal Chemistry Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets Advancement in Infection Control of Opportunistic Pathogen (Aspergillus spp.): Adjunctive Agents
Current Pharmaceutical Biotechnology The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets